Released Aug 14, 2018, before the open
10-Q filed Aug 14, 2018, 45 days after period end · 0001437749-18-015598
Q2 2018 · 10-Q
Revenue$748.14K$748.14K −15.6% vs Q2 2017−11.1% vs Q1 2018
Net Income-$1.66M-$1.66M N/M vs Q2 2017N/M vs Q1 2018
EPS Diluted-$0.15-$0.15 N/M vs Q2 2017N/M vs Q1 2018
Gross Profit-$281,662N/M
Operating Income-$1,655,479N/M
Operating Cash Flowderived-$944,791N/M
Free Cash Flowderived-$980,413N/M
Margins · derived
Gross margin-37.6%−47.9 pt vs Q2 2017
Operating margin-221.3%−19.5 pt vs Q2 2017
Net margin-221.3%−19.5 pt vs Q2 2017
What the release said
The release
Same quarter
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $748.14K | $886.88K | $415.81K | $2.27M |
| Net Income | -$1.66M | -$1.79M | -$1.38M | $753.15K |
| EPS Diluted | -$0.15 | -$0.32 | -$0.29 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR